{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:32:30Z","timestamp":1782937950314,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-022-02410-w","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T20:04:59Z","timestamp":1663358699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Formulation of Topical Flurbiprofen Solid Lipid Nanoparticle Gel Formulation Using Hot Melt Extrusion Technique"],"prefix":"10.1208","volume":"23","author":[{"given":"Arvind","family":"Bagde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanual","family":"Kouagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandip","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"issue":"1","key":"2410_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.26452\/ijrps.v11i1.1831","volume":"11","author":"M Sharadha","year":"2020","unstructured":"Sharadha M, et al. An overview on topical drug delivery system\u2013updated review. International Journal of Research in Pharmaceutical Sciences. 2020;11(1):368\u201385.","journal-title":"International Journal of Research in Pharmaceutical Sciences"},{"issue":"4","key":"2410_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/jnci\/85.4.292","volume":"85","author":"T Griffin","year":"1993","unstructured":"Griffin T, et al. Potentiation of antitumor immunotoxins by liposomal monensin. JNCI: J National Cancer Inst. 1993;85(4):292\u20138.","journal-title":"JNCI: J National Cancer Inst."},{"issue":"1\u20132","key":"2410_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijpharm.2015.04.059","volume":"489","author":"CH Boakye","year":"2015","unstructured":"Boakye CH, Patel K, Singh M. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers. Int J Pharm. 2015;489(1\u20132):106\u201316.","journal-title":"Int J Pharm"},{"issue":"4","key":"2410_CR4","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3109\/10717544.2015.1124472","volume":"23","author":"R Doddapaneni","year":"2016","unstructured":"Doddapaneni R, et al. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer. Drug Delivery. 2016;23(4):1232\u201341.","journal-title":"Drug Delivery"},{"issue":"12","key":"2410_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082581","volume":"8","author":"S Marepally","year":"2013","unstructured":"Marepally S, et al. Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery. PLoS ONE. 2013;8(12): e82581.","journal-title":"PLoS ONE"},{"issue":"11","key":"2410_CR6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2217\/nnm.16.37","volume":"11","author":"K Patel","year":"2016","unstructured":"Patel K, et al. Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer. Nanomedicine. 2016;11(11):1377\u201392.","journal-title":"Nanomedicine"},{"issue":"6","key":"2410_CR7","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1021\/acs.molpharmaceut.6b00187","volume":"13","author":"K Patel","year":"2016","unstructured":"Patel K, et al. Combination approach of YSA peptide anchored docetaxel stealth liposomes with oral antifibrotic agent for the treatment of lung cancer. Mol Pharm. 2016;13(6):2049\u201358.","journal-title":"Mol Pharm"},{"key":"2410_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.colsurfb.2017.01.038","volume":"153","author":"C Godugu","year":"2017","unstructured":"Godugu C, Doddapaneni R, Singh M. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). Colloids Surf, B. 2017;153:208\u201319.","journal-title":"Colloids Surf, B"},{"issue":"10","key":"2410_CR9","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11095-014-1377-4","volume":"31","author":"AR Patel","year":"2014","unstructured":"Patel AR, Chougule M, Singh M. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer. Pharm Res. 2014;31(10):2796\u2013809.","journal-title":"Pharm Res"},{"issue":"7","key":"2410_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1211\/0022357023772","volume":"56","author":"MS Shaik","year":"2004","unstructured":"Shaik MS, Chatterjee A, Singh M. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7\/dox) cell-line. J Pharm Pharmacol. 2004;56(7):899\u2013907.","journal-title":"J Pharm Pharmacol"},{"key":"2410_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"W Mehnert","year":"2012","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012;64:83\u2013101.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"2410_CR12","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/S0142-9612(02)00578-1","volume":"24","author":"D Hou","year":"2003","unstructured":"Hou D, et al. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003;24(10):1781\u20135.","journal-title":"Biomaterials"},{"issue":"1","key":"2410_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/colloids5010018","volume":"5","author":"A Zoabi","year":"2021","unstructured":"Zoabi A, Touitou E, Margulis K. Recent advances in nanomaterials for dermal and transdermal applications. Colloids and Interfaces. 2021;5(1):18.","journal-title":"Colloids and Interfaces"},{"key":"2410_CR14","doi-asserted-by":"crossref","unstructured":"Scioli Montoto S, Muraca G, Ruiz ME. Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects. Front Mol Biosci. 2020;319.","DOI":"10.3389\/fmolb.2020.587997"},{"issue":"1","key":"2410_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-3659(98)00174-6","volume":"59","author":"M Singh","year":"1999","unstructured":"Singh M, Ferdous AJ, Jackson TL. Stealth monensin liposomes as a potentiator of adriamycin in cancer treatment. J Control Release. 1999;59(1):43\u201353.","journal-title":"J Control Release"},{"key":"2410_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0076-6879(09)64009-X","volume":"464","author":"G Patel","year":"2009","unstructured":"Patel G, et al. Nanoliposomal dry powder formulations. Methods Enzymol. 2009;464:167\u201391.","journal-title":"Methods Enzymol"},{"issue":"7","key":"2410_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jsps.2019.08.004","volume":"27","author":"DT Pham","year":"2019","unstructured":"Pham DT, Tran PH, Tran TT. Development of solid dispersion lipid nanoparticles for improving skin delivery. Saudi Pharmaceutical Journal. 2019;27(7):1019\u201324.","journal-title":"Saudi Pharmaceutical Journal"},{"key":"2410_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105296","volume":"149","author":"JS Passos","year":"2020","unstructured":"Passos JS, et al. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. Eur J Pharm Sci. 2020;149: 105296.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2410_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/1061186X.2014.965717","volume":"23","author":"T Geetha","year":"2015","unstructured":"Geetha T, et al. Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer. J Drug Target. 2015;23(2):159\u201369.","journal-title":"J Drug Target"},{"key":"2410_CR20","volume":"3","author":"G Shadambikar","year":"2021","unstructured":"Shadambikar G, et al. Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology. International journal of pharmaceutics: X. 2021;3: 100074.","journal-title":"International journal of pharmaceutics: X"},{"issue":"1","key":"2410_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1208\/s12248-014-9674-8","volume":"17","author":"H Patil","year":"2015","unstructured":"Patil H, et al. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS J. 2015;17(1):194\u2013205.","journal-title":"AAPS J"},{"issue":"4","key":"2410_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.xphs.2016.12.015","volume":"106","author":"AM Bhagurkar","year":"2017","unstructured":"Bhagurkar AM, Repka MA, Murthy SN. A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology. J Pharm Sci. 2017;106(4):1085\u201391.","journal-title":"J Pharm Sci"},{"issue":"4","key":"2410_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s13346-019-00632-3","volume":"9","author":"A Bagde","year":"2019","unstructured":"Bagde A, et al. Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength. Drug Deliv Transl Res. 2019;9(4):816\u201327.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"2410_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/10717540490280697","volume":"11","author":"J-Y Fang","year":"2004","unstructured":"Fang J-Y, et al. Lipid nano\/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Delivery. 2004;11(2):97\u2013105.","journal-title":"Drug Delivery"},{"key":"2410_CR25","unstructured":"Cody SL, Fegley RD, Hoy MR. Enhanced delivery of topical compositions containing flurbiprofen. Google Patents.\u00a01998."},{"key":"2410_CR26","doi-asserted-by":"crossref","unstructured":"Czyrski, A., Determination of the lipophilicity of ibuprofen, naproxen, ketoprofen, and flurbiprofen with thin-layer chromatography. J Chemistry., 2019. 2019.","DOI":"10.1155\/2019\/3407091"},{"issue":"3_suppl","key":"2410_CR27","doi-asserted-by":"publisher","first-page":"59S","DOI":"10.1177\/1091581813488804","volume":"32","author":"MM Fiume","year":"2013","unstructured":"Fiume MM, et al. Safety assessment of triethanolamine and triethanolamine-containing ingredients as used in cosmetics. Int J Toxicol. 2013;32(3_suppl):59S-83S.","journal-title":"Int J Toxicol."},{"issue":"5","key":"2410_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.2042-7158.1997.tb06829.x","volume":"49","author":"SB Kulkarni","year":"1997","unstructured":"Kulkarni SB, Singh M, Betageri GV. Encapsulation, stability and in-vitro release characteristics of liposomal formulations of colchicine. J Pharm Pharmacol. 1997;49(5):491\u20135.","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"2410_CR29","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s11095-017-2244-x","volume":"34","author":"N Chowdhury","year":"2017","unstructured":"Chowdhury N, et al. Liposomes co-loaded with 6-phosphofructo-2-kinase\/fructose-2, 6-biphosphatase 3 (PFKFB3) shRNA plasmid and docetaxel for the treatment of non-small cell lung cancer. Pharm Res. 2017;34(11):2371\u201384.","journal-title":"Pharm Res"},{"issue":"9","key":"2410_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185116","volume":"12","author":"K Affram","year":"2017","unstructured":"Affram K, et al. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging. PLoS ONE. 2017;12(9): e0185116.","journal-title":"PLoS ONE"},{"issue":"5","key":"2410_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1211\/0022357011775947","volume":"53","author":"MS Shaik","year":"2001","unstructured":"Shaik MS, et al. Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs. J Pharm Pharmacol. 2001;53(5):617\u201327.","journal-title":"J Pharm Pharmacol"},{"key":"2410_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.colsurfb.2016.03.036","volume":"143","author":"CH Boakye","year":"2016","unstructured":"Boakye CH, et al. Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention. Colloids Surf, B. 2016;143:156\u201367.","journal-title":"Colloids Surf, B"},{"issue":"3","key":"2410_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/2231-4040.85529","volume":"2","author":"M Akhlaq","year":"2011","unstructured":"Akhlaq M, et al. A simple high-performance liquid chromatographic practical approach for determination of flurbiprofen. Journal of Advanced Pharmaceutical Technology & Research. 2011;2(3):151.","journal-title":"Journal of Advanced Pharmaceutical Technology & Research"},{"issue":"15","key":"2410_CR34","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1016\/S0142-9612(02)00080-7","volume":"23","author":"R Pignatello","year":"2002","unstructured":"Pignatello R, et al. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials. 2002;23(15):3247\u201355.","journal-title":"Biomaterials"},{"issue":"1","key":"2410_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1208\/s12249-007-9009-5","volume":"9","author":"DR Kryscio","year":"2008","unstructured":"Kryscio DR, et al. Spreadability measurements to assess structural equivalence (Q3) of topical formulations\u2014a technical note. AAPS PharmSciTech. 2008;9(1):84\u20136.","journal-title":"AAPS PharmSciTech"},{"key":"2410_CR36","doi-asserted-by":"crossref","unstructured":"Salau O, Bagde A, Kalvala A, Singh M. Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats. Int J Pharm. 2022;624:122016.","DOI":"10.1016\/j.ijpharm.2022.122016"},{"issue":"9","key":"2410_CR37","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s11095-012-0789-2","volume":"29","author":"PR Desai","year":"2012","unstructured":"Desai PR, et al. Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application. Pharm Res. 2012;29(9):2587\u2013600.","journal-title":"Pharm Res"},{"issue":"2","key":"2410_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tiv.2009.08.019","volume":"24","author":"R Mallampati","year":"2010","unstructured":"Mallampati R, et al. Evaluation of EpiDerm full thickness-300 (EFT-300) as an in vitro model for skin irritation: studies on aliphatic hydrocarbons. Toxicol In Vitro. 2010;24(2):669\u201376.","journal-title":"Toxicol In Vitro"},{"issue":"1\u20133","key":"2410_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tox.2007.05.005","volume":"237","author":"SV Fulzele","year":"2007","unstructured":"Fulzele SV, et al. Estimation of proinflammatory biomarkers of skin irritation by dermal microdialysis following exposure with irritant chemicals. Toxicology. 2007;237(1\u20133):77\u201388.","journal-title":"Toxicology"},{"issue":"2","key":"2410_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.toxlet.2004.04.036","volume":"153","author":"R Babu","year":"2004","unstructured":"Babu R, Chatterjee A, Singh M. Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane. Toxicol Lett. 2004;153(2):255\u201366.","journal-title":"Toxicol Lett"},{"issue":"1","key":"2410_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1023\/B:PHAM.0000012157.80716.73","volume":"21","author":"RJ Babu","year":"2004","unstructured":"Babu RJ, et al. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. Pharm Res. 2004;21(1):108\u201313.","journal-title":"Pharm Res"},{"issue":"3","key":"2410_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.toxlet.2008.12.012","volume":"185","author":"RR Patlolla","year":"2009","unstructured":"Patlolla RR, et al. Dermal microdialysis of inflammatory markers induced by aliphatic hydrocarbons in rats. Toxicol Lett. 2009;185(3):168\u201374.","journal-title":"Toxicol Lett"},{"issue":"12","key":"2410_CR43","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1517\/17425247.2014.935335","volume":"11","author":"MH Aburahma","year":"2014","unstructured":"Aburahma MH, Badr-Eldin SM. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv. 2014;11(12):1865\u201383.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"2410_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1166\/jbn.2015.1902","volume":"11","author":"Z Yong-Tai","year":"2015","unstructured":"Yong-Tai Z, et al. Solid lipid nanoparticles formulated for transdermal aconitine administration and evaluated in vitro and in vivo. J Biomed Nanotechnol. 2015;11(2):351\u201361.","journal-title":"J Biomed Nanotechnol"},{"issue":"18","key":"2410_CR45","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.3390\/molecules26185432","volume":"26","author":"H Hassan","year":"2021","unstructured":"Hassan H, et al. Central composite design for formulation and optimization of solid lipid nanoparticles to enhance oral bioavailability of acyclovir. Molecules. 2021;26(18):5432.","journal-title":"Molecules"},{"issue":"6","key":"2410_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ajps.2017.09.006","volume":"13","author":"T Tran","year":"2018","unstructured":"Tran T, Rades T, M\u00fcllertz A. Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor\u00ae RH40 using experimental design. Asian J Pharm Sci. 2018;13(6):536\u201345.","journal-title":"Asian J Pharm Sci"},{"issue":"5","key":"2410_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/gels8050277","volume":"8","author":"MFA Khan","year":"2022","unstructured":"Khan MFA, et al. Hydrogel containing solid lipid nanoparticles loaded with argan oil and simvastatin: preparation, in vitro and ex vivo assessment. Gels. 2022;8(5):277.","journal-title":"Gels"},{"key":"2410_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1590\/S1984-82502015000100007","volume":"51","author":"VCKN Deuschle","year":"2015","unstructured":"Deuschle VCKN, et al. Physical chemistry evaluation of stability, spreadability, in vitro antioxidant, and photo-protective capacities of topical formulations containing Calendula officinalis L. leaf extract. Brazil J Pharm Sci. 2015;51:63\u201375.","journal-title":"Brazil J Pharm Sci."},{"issue":"5","key":"2410_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2174\/1567201811310050006","volume":"10","author":"N Patere","year":"2013","unstructured":"Patere N, S, et al. Compritol\u00ae 888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. Curr Drug Deliv. 2013;10(5):548\u201356.","journal-title":"Curr Drug Deliv."},{"issue":"3","key":"2410_CR50","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/pharmaceutics13030328","volume":"13","author":"G Mancini","year":"2021","unstructured":"Mancini G, et al. Increased therapeutic efficacy of SLN containing etofenamate and ibuprofen in topical treatment of inflammation. Pharmaceutics. 2021;13(3):328.","journal-title":"Pharmaceutics"},{"key":"2410_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101758","volume":"57","author":"CV Pham","year":"2020","unstructured":"Pham CV, et al. Development of ibuprofen-loaded solid lipid nanoparticle-based hydrogels for enhanced in vitro dermal permeation and in vivo topical anti-inflammatory activity. Journal of Drug Delivery Science and Technology. 2020;57: 101758.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"4","key":"2410_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10717540590952591","volume":"12","author":"S Jain","year":"2005","unstructured":"Jain S, et al. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Delivery. 2005;12(4):207\u201315.","journal-title":"Drug Delivery"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02410-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02410-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02410-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T23:06:26Z","timestamp":1667084786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02410-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02410-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"257"}}